GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » EV-to-Revenue

Dis-Chem Pharmacies (JSE:DCP) EV-to-Revenue : 0.97 (As of May. 22, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Dis-Chem Pharmacies's enterprise value is R33,005 Mil. Dis-Chem Pharmacies's Revenue for the trailing twelve months (TTM) ended in Aug. 2023 was R34,191 Mil. Therefore, Dis-Chem Pharmacies's EV-to-Revenue for today is 0.97.

The historical rank and industry rank for Dis-Chem Pharmacies's EV-to-Revenue or its related term are showing as below:

JSE:DCP' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.74   Med: 1.14   Max: 2.29
Current: 0.97

During the past 10 years, the highest EV-to-Revenue of Dis-Chem Pharmacies was 2.29. The lowest was 0.74. And the median was 1.14.

JSE:DCP's EV-to-Revenue is ranked better than
71.82% of 660 companies
in the Healthcare Providers & Services industry
Industry Median: 1.83 vs JSE:DCP: 0.97

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Dis-Chem Pharmacies's stock price is R33.53. Dis-Chem Pharmacies's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 was R39.80. Therefore, Dis-Chem Pharmacies's PS Ratio for today is 0.84.


Dis-Chem Pharmacies EV-to-Revenue Historical Data

The historical data trend for Dis-Chem Pharmacies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies EV-to-Revenue Chart

Dis-Chem Pharmacies Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 0.91 0.88 1.11 0.86

Dis-Chem Pharmacies Semi-Annual Data
Feb14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.11 - 0.86 -

Competitive Comparison of Dis-Chem Pharmacies's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's EV-to-Revenue falls into.



Dis-Chem Pharmacies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Dis-Chem Pharmacies's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=33004.853/34191.437
=0.97

Dis-Chem Pharmacies's current Enterprise Value is R33,005 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's Revenue for the trailing twelve months (TTM) ended in Aug. 2023 was R34,191 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies  (JSE:DCP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Dis-Chem Pharmacies's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=33.53/39.795
=0.84

Dis-Chem Pharmacies's share price for today is R33.53.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Aug. 2023 was R39.80.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dis-Chem Pharmacies (JSE:DCP) Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.